HCAT Health Catalyst, Inc.

Nasdaq healthcatalyst.com


$ 3.18 $ 0.06 (1.92 %)    

Tuesday, 21-Oct-2025 15:59:56 EDT
QQQ $ 610.75 $ -0.16 (-0.03 %)
DIA $ 469.29 $ 2.20 (0.47 %)
SPY $ 671.35 $ -0.01 (0 %)
TLT $ 91.98 $ 0.45 (0.49 %)
GLD $ 379.24 $ -25.91 (-6.43 %)
$ 3.18
$ 3.09
$ 3.18 x 116
$ 3.54 x 30
$ 3.05 - $ 3.22
$ 2.52 - $ 9.24
398,657
na
223.79M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 02-28-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-23-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-in-line-on-health-catalyst-lowers-price-target-to-3

Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and lowers the price ta...

 keybanc-maintains-overweight-on-health-catalyst-lowers-price-target-to-4

Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from ...

 cantor-fitzgerald-reiterates-neutral-on-health-catalyst-maintains-4-price-target

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Neutral and maintains $4 price target.

 btig-reiterates-neutral-on-health-catalystto-neutral

BTIG analyst David Larsen reiterates Health Catalyst (NASDAQ:HCAT) from Neutral to Neutral.

 canaccord-genuity-maintains-buy-on-health-catalyst-lowers-price-target-to-5

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from ...

 evercore-isi-group-maintains-in-line-on-health-catalyst-raises-price-target-to-4

Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and raises the price ta...

 piper-sandler-downgrades-health-catalyst-to-neutral-lowers-price-target-to-4

Piper Sandler analyst Jessica Tassan downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Neutral and lowers the pric...

 cantor-fitzgerald-downgrades-health-catalyst-to-neutral-lowers-price-target-to-4

Cantor Fitzgerald analyst Sarah James downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Neutral and lowers the pri...

 stifel-maintains-hold-on-health-catalyst-lowers-price-target-to-45

Stifel analyst David Grossman maintains Health Catalyst (NASDAQ:HCAT) with a Hold and lowers the price target from $5.5 to $...

 health-catalyst-ceo-dan-burton-to-step-down-in-2026-board-begins-search-for-successor

Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and se...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION